000 01431 a2200397 4500
005 20250513142848.0
264 0 _c19980617
008 199806s 0 0 eng d
022 _a0106-9543
024 7 _a10.1111/j.1600-0676.1998.tb00139.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBrind, A M
245 0 0 _aNucleoside analogue therapy in fibrosing cholestatic hepatitis--a case report in an HBsAg positive renal transplant recipient.
_h[electronic resource]
260 _bLiver
_cApr 1998
300 _a134-9 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article; Review
650 0 4 _aCholestasis, Intrahepatic
_xdrug therapy
650 0 4 _aDNA, Viral
_xanalysis
650 0 4 _aFatal Outcome
650 0 4 _aHepatitis B e Antigens
_xanalysis
650 0 4 _aHepatitis B virus
_xdrug effects
650 0 4 _aHepatitis B, Chronic
_xblood
650 0 4 _aHumans
650 0 4 _aImmunocompromised Host
650 0 4 _aImmunohistochemistry
650 0 4 _aKidney Transplantation
650 0 4 _aLamivudine
_xtherapeutic use
650 0 4 _aLiver
_xpathology
650 0 4 _aLiver Function Tests
650 0 4 _aMiddle Aged
650 0 4 _aReverse Transcriptase Inhibitors
_xtherapeutic use
700 1 _aBennett, M K
700 1 _aBassendine, M F
773 0 _tLiver
_gvol. 18
_gno. 2
_gp. 134-9
856 4 0 _uhttps://doi.org/10.1111/j.1600-0676.1998.tb00139.x
_zAvailable from publisher's website
999 _c9555566
_d9555566